Get the Stockscreener App
2.69
0.37%
0.010
Codexis Inc stock is traded at $2.69, with a volume of 780.65K.
It is up +0.37% in the last 24 hours and up +12.08% over the past month.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.68
Open:
$2.62
24h Volume:
780.65K
Relative Volume:
0.91
Market Cap:
$222.85M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-2.4234
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
-13.50%
1M Performance:
+12.08%
6M Performance:
-35.80%
1Y Performance:
-22.70%
1-Day Range:
$2.58
$2.809
1-Week Range:
$2.58
$3.145
52-Week Range:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.69 | 222.02M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
How many analysts rate Codexis Inc. as a “Buy”Chart Pattern Insights Backed By Experts - jammulinksnews.com
Visual analytics tools that track Codexis Inc. performanceFree Weekly Chart Analysis With Entry Advice - Newser
Published on: 2025-08-02 03:05:41 - Newser
Volume spikes in Codexis Inc. stock – what they meanFree Entry Points For Growing Stocks - Newser
Why is Codexis Inc. stock attracting strong analyst attentionExpert Picks Target Finder For Consistent Profits - jammulinksnews.com
Candlestick Reversal Detected on Codexis Inc.’s ChartEntry Plan for Oversold Reversal Stocks Released - metal.it
Why Codexis Inc. stock attracts strong analyst attentionStrategy Builder for Growth Focused Traders - Newser
Applying big data sentiment scoring on Codexis Inc.Low Risk Trade Timing with Analysis Metrics - Newser
Visual trend scoring systems applied to Codexis Inc.Swing Trade Entry and Exit Point Analysis - Newser
Codexis Inc. stock chart pattern explainedLong Term Stock Planner with Safety Checks - Newser
Opaleye Management Makes Bold Move with Codexis Stock Purchase - TipRanks
When is Codexis Inc. stock expected to show significant growthWealth Building Target Finder To Watch Now - jammulinksnews.com
Pattern recognition hints at Codexis Inc. upsideSwing Trade Entry With Volume Triggers Released - metal.it
How Codexis Inc. stock performs during market volatilityTechnical Entry Plan with Risk Minimization - Newser
What makes Codexis Inc. stock price move sharplyStable Profit Zone and Loss Control Analysis - Newser
What is Codexis Inc. company’s growth strategySwing Trade Insights With Proven Results - jammulinksnews.com
Codexis to Report Second Quarter 2025 Financial Results on August 13 - GlobeNewswire
Is Codexis Inc. stock ready for a breakoutAI-Powered Stock Trend Movement Analysis - Newser
Is Codexis Inc. a growth stock or a value stockRetirement Planning Review With Proven Results - jammulinksnews.com
Codexis Inc. Rebounds From Oversold Zone — Now WhatSwing Trading Plan With Smart Signals in Review - beatles.ru
Drawdown in Codexis Inc. May Be Nearing EndScalable Portfolio Growth Suggestions Released - metal.it
Is Codexis Inc. stock overvalued or undervaluedCapitalize on market momentum for big wins - jammulinksnews.com
How strong is Codexis Inc. company’s balance sheetBreakout portfolio performance - jammulinksnews.com
Codexis Shares Dip But Analysts See Big Upside Ahead - Finimize
Private Advisor Group LLC Has $922,000 Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Pattern recognition hints at Codexis Inc. upside Free AI Driven Stock Trend Forecast - Newser
What are Codexis Inc. company’s key revenue driversGet exclusive access to premium stock research - jammulinksnews.com
What catalysts could drive Codexis Inc. stock higher in 2025Capitalize on high-yield stocks early - jammulinksnews.com
How does Codexis Inc. compare to its industry peersBuild a portfolio that withstands market volatility - jammulinksnews.com
What is the dividend policy of Codexis Inc. stockFastest-growing stock picks - jammulinksnews.com
Codexis Inc. Stock Support and Resistance Levels You Should KnowLong Term Secure Gain Stocks - Newser
Codexis Confronts Trade Policy Challenges: Tariffs and Sanctions Threaten Operations - TipRanks
What analysts say about Codexis Inc. stockRapid growth opportunities - Autocar Professional
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):